PT Saptausaha Gemilangindah Tbk (SAGE)
Jul 31, 2025 - SAGE was delisted (reason: acquired by SUPN)
8.68
-0.02 (-0.23%)
Inactive · Last trade price
on Jul 30, 2025
Sage Therapeutics Employees
PT Saptausaha Gemilangindah Tbk had 353 employees as of December 31, 2024. The number of employees decreased by 134 or -27.52% compared to the previous year.
Employees
353
Change (1Y)
-134
Growth (1Y)
-27.52%
Revenue / Employee
$10,191
Profits / Employee
-$3,391
Market Cap
9.32M
Employees Chart
Employees History
SAGE News
- 14 days ago - Sage Therapeutics Announces Second Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE - Business Wire
- 7 weeks ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 2 months ago - These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News - Benzinga
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Accesswire
- 2 months ago - Top 3 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - PRNewsWire
- 2 months ago - Sage Therapeutics Stock Soars 35% After Sale to Supernus. What We Know. - Barrons